Cargando…

Prevalence of Selected Single-Nucleotide Variants in Patients with Neuroendocrine Tumors—Potential Clinical Relevance

Introduction: The genetic basis of neuroendocrine tumors (NETs), whose incidence is continuously increasing, is still not fully defined. The majority of NETs are sporadic, and only a small percentage occur as part of hereditary genetic syndromes. However, the associations of multiple genetic variant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurzyńska, Anna, Pach, Dorota, Skalniak, Anna Elżbieta, Stefańska, Agnieszka, Opalińska, Marta, Przybylik-Mazurek, Elwira, Hubalewska-Dydejczyk, Alicja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573749/ https://www.ncbi.nlm.nih.gov/pubmed/36233401 http://dx.doi.org/10.3390/jcm11195536

Ejemplares similares

Molecular analysis and genotype-phenotype correlations in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency from southern Poland — experience of a clinical center
por: Kurzyńska, Anna, et al.
Publicado: (2022)

Modifier Role of Common RET Variants in Sporadic Medullary Thyroid Carcinoma
por: Skalniak, Anna, et al.
Publicado: (2021)

What Cut-off Value of 17-Hydroxyprogesterone Should Be an Indication to Perform a 250 µg Cosyntropin Stimulation Test When NCCAH Is Suspected? - a Retrospective Study
por: Domagala, Bartosz, et al.
Publicado: (2021)

Adrenal bleeding due to pheochromocytoma - A call for algorithm
por: Rzepka, Ewelina, et al.
Publicado: (2022)

Ectopic ACTH syndrome of different origin—Diagnostic approach and clinical outcome. Experience of one Clinical Centre
por: Paleń-Tytko, Joanna Ewelina, et al.
Publicado: (2020)

Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors
por: Opalińska, Marta, et al.
Publicado: (2021)

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
por: Sowa-Staszczak, Anna, et al.
Publicado: (2011)

Hyperinsulinemic Hypoglycemia in Three Generations of a Family with Glucokinase Activating Mutation, c.295T>C (p.Trp99Arg)
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2021)

Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma
por: Opalińska, Marta, et al.
Publicado: (2021)

AIP gene germline variants in adult Polish patients with apparently sporadic pituitary macroadenomas
por: Trofimiuk-Müldner, Małgorzata, et al.
Publicado: (2023)

Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome?
por: Sowa-Staszczak, Anna, et al.
Publicado: (2021)

Glucagon-Like Peptide-1 Receptor Imaging with [Lys(40)(Ahx-HYNIC-(99m)Tc/EDDA)NH(2)]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report
por: Pach, D., et al.
Publicado: (2013)

Potential value of pre- and post-therapy [68Ga]Ga-DOTA-TATE PET/CT in the prognosis of response to PRRT in disseminated neuroendocrine tumors
por: Opalińska, Marta, et al.
Publicado: (2022)

Heterogeneity of the Clinical Presentation of the MEN1 LRG_509 c.781C>T (p.Leu261Phe) Variant Within a Three-Generation Family
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2021)

Additional Value of [18F]FDG PET/CT in Detection of Suspected Malignancy in Patients with Paraneoplastic Neurological Syndromes Having Negative Results of Conventional Radiological Imaging
por: Opalińska, Marta, et al.
Publicado: (2022)

MON-013 Nutritional Approach To Autoimmune Thyroiditis (AIT) - The Patients’ And Medical Professionals’ View.
por: Trofimiuk-Muldner, Malgorzata, et al.
Publicado: (2019)

PSAT384 Familial Non-Medullary Thyroid Cancer — Does The Number Of Alanine Residues In The FOXE1 Gene Play A Role?
por: Trofimiuk-Muldner, Malgorzata, et al.
Publicado: (2022)

MON-300 AIP Gene Germline Mutations in Non-Selected Patients with Apparently Sporadic Pituitary Macrodenomas
por: Trofimiuk-Muldner, Malgorzata, et al.
Publicado: (2020)

Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients
por: Opalinska, Marta, et al.
Publicado: (2012)

Pituitary insufficiency following traumatic thoracic injury in an adolescent male patient: A case report and literature review
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2017)

MON-584 Iodine Nutrition Status in Pregnancy: Is the Situation in Poland Improving?
por: Trofimiuk-Muldner, Malgorzata, et al.
Publicado: (2019)

Clinical results of radionuclide therapy of neuroendocrine tumours with (90)Y-DOTATATE and tandem (90)Y/(177)Lu-DOTATATE: which is a better therapy option?
por: Kunikowska, Jolanta, et al.
Publicado: (2011)

How far are we from understanding the genetic basis of Hashimoto’s thyroiditis?
por: Hubalewska-Dydejczyk, Alicja
Publicado: (2013)

Glucagon-like peptide-1 receptor imaging with [Lys(40)(Ahx-HYNIC-(99m)Tc/EDDA)NH(2)]-exendin-4 for the detection of insulinoma
por: Sowa-Staszczak, Anna, et al.
Publicado: (2012)

Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor
por: Opalinska, Marta, et al.
Publicado: (2023)

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
por: Kos-Kudła, Beata, et al.
Publicado: (2017)

Comment on: Somatostatin receptor SPECT
por: Hubalewska-Dydejczyk, Alicja, et al.
Publicado: (2012)

The development of guidelines for management of thyroid diseases in pregnancy – current status
por: Hubalewska-Dydejczyk, Alicja, et al.
Publicado: (2015)

THU099 The Challenging Management Of Silent Corticotroph PitNET—From Very Aggressive To Mild Course Of Disease During Long Follow Up
por: Bogusławska, Anna, et al.
Publicado: (2023)

THU064 Clinical, Radiological Characteristics And Response To Somatostatin Analogues Of Acromegaly Patients With Different Patterns Of Growth Hormone Response After Oral Glucose Load
por: Godlewska, Magdalena, et al.
Publicado: (2023)

Efficacy and complications of neurosurgical treatment of acromegaly
por: Krzentowska-Korek, Anna, et al.
Publicado: (2010)

Functional and Morphological Changes in the Visual Pathway in Patients with Graves’ Orbitopathy
por: Jagiełło-Korzeniowska, Agnieszka, et al.
Publicado: (2022)

Traumatic brain injuries induced pituitary dysfunction: a call for algorithms
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2020)

Pregnancy, thyroid, and the potential use of selenium
por: Hubalewska-Dydejczyk, Alicja, et al.
Publicado: (2019)

Individualized medical treatment options in Cushing disease
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2022)

THU019 Osilodrostat As An Emergency Alternative For Hypercortisolism In A Patient With An Impaired Liver Function
por: Minasyan, Mari, et al.
Publicado: (2023)

Current iodine nutrition status in Poland (2017): is the Polish model of obligatory iodine prophylaxis able to eliminate iodine deficiency in the population?
por: Trofimiuk-Müldner, Małgorzata, et al.
Publicado: (2020)

How much of the predisposition to Hashimoto’s thyroiditis can be explained based on previously reported associations?
por: Jabrocka-Hybel, A., et al.
Publicado: (2018)

[(111)In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial
por: Lezaic, Luka, et al.
Publicado: (2022)

FRI111 Venous Thromboembolism In Cushing Syndrome - A Call For Standardized Anticoagulation Regimen In Hypercortisolism
por: Minasyan, Mari, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kteqfjfn1lcvq9lf5k3gni95hv